Volatile profiling distinguishes Streptococcus pyogenes from other respiratory streptococcal species.
Autor: | Berna AZ; Department of Pediatrics, Washington University School of Medicine , St. Louis, Missouri, USA.; Department of Pediatrics, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania, USA., Merriman JA; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.; Microbiome Therapies Initiative, Stanford University , Palo Alto, California, USA., Mellett L; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA., Parchment DK; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.; Vaccine Research Center, National Institute of Allergy and Infectious Diseases , Bethesda, Maryland, USA., Caparon MG; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA., Odom John AR; Department of Pediatrics, Washington University School of Medicine , St. Louis, Missouri, USA.; Department of Pediatrics, Children's Hospital of Philadelphia , Philadelphia, Pennsylvania, USA.; Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | MSphere [mSphere] 2023 Oct 24; Vol. 8 (5), pp. e0019423. Date of Electronic Publication: 2023 Oct 04. |
DOI: | 10.1128/msphere.00194-23 |
Abstrakt: | Sore throat is one of the most common complaints encountered in the ambulatory clinical setting. Rapid, culture-independent diagnostic techniques that do not rely on pharyngeal swabs would be highly valuable as a point-of-care strategy to guide outpatient antibiotic treatment. Despite the promise of this approach, efforts to detect volatiles during oropharyngeal infection have yet been limited. In our research study, we sought to evaluate for specific bacterial volatile organic compounds (VOC) biomarkers in isolated cultures in vitro , in order to establish proof-of-concept prior to initial clinical studies of breath biomarkers. A particular challenge for the diagnosis of pharyngitis due to Streptococcus pyogenes is the likelihood that many metabolites may be shared by S. pyogenes and other related oropharyngeal colonizing bacterial species. Therefore, we evaluated whether sufficient metabolic differences are present, which distinguish the volatile metabolome of Group A streptococci from other streptococcal species that also colonize the respiratory mucosa, such as Streptococcus pneumoniae and Streptococcus intermedius . In this work, we identified 27 discriminatory VOCs ( q -values < 0.05), composed of aldehydes, alcohols, nitrogen-containing compounds, hydrocarbons, ketones, aromatic compounds, esters, ethers, and carboxylic acid. From this group of volatiles, we identify candidate biomarkers that distinguish S. pyogenes from other species and establish highly produced VOCs that indicate the presence of S. pyogenes in vitro , supporting future breath-based diagnostic testing for streptococcal pharyngitis. IMPORTANCE Acute pharyngitis accounts for approximately 15 million ambulatory care visits in the United States. The most common and important bacterial cause of pharyngitis is Streptococcus pyogenesis , accounting for 15%-30% of pediatric pharyngitis. Distinguishing between bacterial and viral pharyngitis is key to management in US practice. The culture of a specimen obtained by a throat swab is the standard laboratory procedure for the microbiologic confirmation of pharyngitis; however, this method is time-consuming, which delays appropriate treatment. If left untreated, S. pyogenes pharyngitis may lead to local and distant complications. In this study, we characterized the volatile metabolomes of S. pyogenes and other related oropharyngeal colonizing bacterial species. We identify candidate biomarkers that distinguish S. pyogenes from other species and provide evidence to support future breath-based diagnostic testing for streptococcal pharyngitis. Competing Interests: The authors declare no conflict of interest. |
Databáze: | MEDLINE |
Externí odkaz: |